Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach.
Petra DenigPeter J C StuijtPublished in: Expert review of clinical pharmacology (2024)
There is a need for rigorous development and evaluation of intervention strategies aimed at proactive deprescribing of cardiometabolic medication. To address challenges at different levels, these should be multifaceted interventions. All stakeholders must become aware of the relevance of deintensifying medication in this population. Education and training for HCPs and patients should support patient-centered communication and shared decision-making. Development of procedures and tools to select eligible patients and conduct targeted medication reviews are important for implementation of deprescribing in routine care.
Keyphrases
- healthcare
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- randomized controlled trial
- primary care
- quality improvement
- prognostic factors
- peritoneal dialysis
- systematic review
- physical activity
- emergency department
- adverse drug
- pain management
- drug delivery
- electronic health record